These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 4728340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK, Chase TN, Colburn RW, Kopin IJ.
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG, Scotti de Carolis A, Liuzzi A, Massotti M.
    Adv Biochem Psychopharmacol; 1974 Jul; 10():109-20. PubMed ID: 4546514
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW, Sparber SB.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract] [Full Text] [Related]

  • 7. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH, VAN Woert MH.
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.
    Glowinski J, Iversen LL.
    J Neurochem; 1966 Aug; 13(8):655-69. PubMed ID: 5950056
    [No Abstract] [Full Text] [Related]

  • 10. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC, Ratner M, Gold CJ, Clouet DH.
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract] [Full Text] [Related]

  • 11. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA, Chalmers JP, Cottman K, Lytle LD, Wurtman RJ.
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract] [Full Text] [Related]

  • 12. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG, Poirier LJ.
    Brain Res; 1974 Aug 23; 76(3):401-12. PubMed ID: 4546739
    [No Abstract] [Full Text] [Related]

  • 13. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L, Cann F, Karczmar AG, Kindel G, Longo VG.
    Pharmacol Biochem Behav; 1973 Aug 23; 1(1):35-40. PubMed ID: 4775581
    [No Abstract] [Full Text] [Related]

  • 14. Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine).
    Zieliński M, Janiec W, Herman ZS.
    Pol J Pharmacol Pharm; 1973 Aug 23; 25(1):17-22. PubMed ID: 4149574
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P, Roberge AG, Boucher R, Poirier LJ.
    J Pharmacol Exp Ther; 1973 Oct 23; 187(1):15-26. PubMed ID: 4746324
    [No Abstract] [Full Text] [Related]

  • 20. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH, Taylor KM, Horn AS, Coyle JT.
    Res Publ Assoc Res Nerv Ment Dis; 1972 Oct 23; 50():359-75. PubMed ID: 4341952
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.